Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical development by Citius Pharmaceuticals and currently in Phase III for Fungal Infections. According to GlobalData, Phase ...

MG introduced the Majestor three-row SUV at the Bharat Mobility Expo in India. The new SUV is a basically rebadged Maxus/LDV D90. MG describes the Majestor as the “tallest, longest, and widest ...

Even though the December quarter (Q3FY25) earnings of domestic IT majors TCS, Infosys, HCL Tech, and Wipro were mixed, they did not bring many disappointments. This has raised hopes that the worst ...

Minocycline hydrochloride ER is under clinical development by Promius Pharma and currently in Pre-Registration for Rosacea. According to GlobalData, Pre-Registration drugs for Rosacea have a 100% ...

The M9 positions MG in the premium electric MPV segment and will be offered exclusively through the brand's 'Select' dealerships MG to retail the premium M9 MPV via its new ‘Select’ dealerships.

Speaking to The Straits Times in an exclusive interview on Jan 9 at MG’s exhibition booth at Suntec Singapore Convention and Exhibition Centre, the 76-year-old motor tycoon is driven to take a ...

Mumbai: HCL Technologies slumped over 8% and dragged other information technology (IT) stocks lower on Tuesday due to lower-than-expected revenue guidance after its third-quarter results. The Nifty IT ...

Hikma will continue producing its 8 mg naloxone HCl nasal spray in its Columbus, Ohio manufacturing facility and will provide it to Emergent as its exclusive commercial partner. "We are thrilled ...

HCL Tech Shares: Stocks tumble over 9% after Q3 earnings (Image: Reuters) HCL Tech Share Price: HCL Technologies saw its shares take a sharp plunge on Tuesday January 14. The stock began trading ...

HCL Technologies shares dropped 9.23% after the company reported a 6% net profit growth for Q3 at Rs 4,591 crore. Revenue rose to Rs 29,890 crore. New deal bookings reached $2.1 billion. Analysts ...

Analysts noted that despite delivering a solid financial performance led by a sharp uptick in deal wins, both TCS and HCL Tech faced pressure due to higher expectations on the Street. India's ...